290 related articles for article (PubMed ID: 18443896)
1. Human S100A12: a novel key player in inflammation?
Pietzsch J; Hoppmann S
Amino Acids; 2009 Mar; 36(3):381-9. PubMed ID: 18443896
[TBL] [Abstract][Full Text] [Related]
2. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
[TBL] [Abstract][Full Text] [Related]
3. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation.
Buhimschi IA; Zhao G; Pettker CM; Bahtiyar MO; Magloire LK; Thung S; Fairchild T; Buhimschi CS
Am J Obstet Gynecol; 2007 Feb; 196(2):181.e1-13. PubMed ID: 17306673
[TBL] [Abstract][Full Text] [Related]
4. S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.
Oesterle A; Bowman MA
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2496-507. PubMed ID: 26515415
[TBL] [Abstract][Full Text] [Related]
5. Multiple structural states of S100A12: A key to its functional diversity.
Moroz OV; Dodson GG; Wilson KS; Lukanidin E; Bronstein IB
Microsc Res Tech; 2003 Apr; 60(6):581-92. PubMed ID: 12645006
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease.
Foell D; Kucharzik T; Kraft M; Vogl T; Sorg C; Domschke W; Roth J
Gut; 2003 Jun; 52(6):847-53. PubMed ID: 12740341
[TBL] [Abstract][Full Text] [Related]
7. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
[TBL] [Abstract][Full Text] [Related]
8. EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes.
Huang SM; Chang YH; Chao YC; Lin JA; Wu CH; Lai CY; Chan KC; Tseng ST; Yen GC
Mol Nutr Food Res; 2013 Dec; 57(12):2264-8. PubMed ID: 23901023
[TBL] [Abstract][Full Text] [Related]
9. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells.
Hsieh HL; Schäfer BW; Weigle B; Heizmann CW
Biochem Biophys Res Commun; 2004 Apr; 316(3):949-59. PubMed ID: 15033494
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels.
Kim HS; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
Nephrology (Carlton); 2013 Dec; 18(12):777-82. PubMed ID: 24124651
[TBL] [Abstract][Full Text] [Related]
11. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules.
Foell D; Wittkowski H; Vogl T; Roth J
J Leukoc Biol; 2007 Jan; 81(1):28-37. PubMed ID: 16943388
[TBL] [Abstract][Full Text] [Related]
12. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
[TBL] [Abstract][Full Text] [Related]
13. Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: impact of glycemic control with insulin and relation with clinical outcome.
Ingels C; Derese I; Wouters PJ; Van den Berghe G; Vanhorebeek I
Shock; 2015 Feb; 43(2):109-16. PubMed ID: 25394242
[TBL] [Abstract][Full Text] [Related]
14. Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo.
Hoppmann S; Steinbach J; Pietzsch J
Int J Biochem Cell Biol; 2010 May; 42(5):651-61. PubMed ID: 20025991
[TBL] [Abstract][Full Text] [Related]
15. Structure of the human S100A12-copper complex: implications for host-parasite defence.
Moroz OV; Antson AA; Grist SJ; Maitland NJ; Dodson GG; Wilson KS; Lukanidin E; Bronstein IB
Acta Crystallogr D Biol Crystallogr; 2003 May; 59(Pt 5):859-67. PubMed ID: 12777802
[TBL] [Abstract][Full Text] [Related]
16. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels.
Myles A; Viswanath V; Singh YP; Aggarwal A
J Rheumatol; 2011 Sep; 38(9):1994-9. PubMed ID: 21724696
[TBL] [Abstract][Full Text] [Related]
17. Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function.
Moroz OV; Burkitt W; Wittkowski H; He W; Ianoul A; Novitskaya V; Xie J; Polyakova O; Lednev IK; Shekhtman A; Derrick PJ; Bjoerk P; Foell D; Bronstein IB
BMC Biochem; 2009 Apr; 10():11. PubMed ID: 19386136
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4.
Foell D; Wittkowski H; Kessel C; Lüken A; Weinhage T; Varga G; Vogl T; Wirth T; Viemann D; Björk P; van Zoelen MA; Gohar F; Srikrishna G; Kraft M; Roth J
Am J Respir Crit Care Med; 2013 Jun; 187(12):1324-34. PubMed ID: 23611140
[TBL] [Abstract][Full Text] [Related]
19. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
[TBL] [Abstract][Full Text] [Related]
20. Establishment of in vitro binding assay of high mobility group box-1 and S100A12 to receptor for advanced glycation endproducts: heparin's effect on binding.
Liu R; Mori S; Wake H; Zhang J; Liu K; Izushi Y; Takahashi HK; Peng B; Nishibori M
Acta Med Okayama; 2009 Aug; 63(4):203-11. PubMed ID: 19727205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
